Literature DB >> 14999603

Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster.

Kayoko Suzuki1, Tetsushi Yoshikawa, Akiko Tomitaka, Kayoko Matsunaga, Yoshizo Asano.   

Abstract

We examined the excretion of varicella zoster virus (VZV) in hospitalized patients with herpes zoster localized to the thoracic region whose skin lesions were covered with either hydrocolloid dressing agents (hydrocolloid group) or conventional gauze bandages (gauze group). The presence of VZV DNA in swab samples from lesion coverings, the throat, and filters of air purifiers was examined by use of a sensitive polymerase chain reaction assay. For the hydrocolloid group, VZV was detected in none of the samples from lesion coverings or air purifier filters; for the gauze group, VZV DNA was detected in samples from gauze coverings and air purifier filters for all 6 patients. VZV DNA was detected less frequently in throat samples from patients in the hydrocolloid group than in those from patients in the gauze group. The results of the present study suggest that hydrocolloid dressing agents prevent excretion of aerosolized VZV DNA from skin lesions of patients with localized herpes zoster.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999603     DOI: 10.1086/382029

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.

Authors:  Jennifer A Johnson; Karen C Bloch; Bich N Dang
Journal:  Clin Infect Dis       Date:  2011-01-27       Impact factor: 9.079

2.  Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster.

Authors:  Karen C Bloch; James G Johnson
Journal:  J Infect Dis       Date:  2012-03-27       Impact factor: 5.226

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 4.  Methods for sampling of airborne viruses.

Authors:  Daniel Verreault; Sylvain Moineau; Caroline Duchaine
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

Review 5.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

6.  Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.

Authors:  Kristen Haberthur; Christine Meyer; Nicole Arnold; Flora Engelmann; Daniel R Jeske; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Authors:  Christine Meyer; Flora Engelmann; Nicole Arnold; David L Krah; Jan ter Meulen; Kristen Haberthur; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

Review 8.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 9.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaques.

Authors:  Kristen Haberthur; Aubrey Kraft; Nicole Arnold; Byung Park; Christine Meyer; Mark Asquith; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.